They’re fast-tracking the testing and regulatory review of vaccines with no guarantee they will prove effective. They’re building and re-tooling plants for vaccines with slim chances of being approved. They’re placing orders for vaccines that, in the end, are unlikely to be produced.
It’s the new pandemic paradigm, focused on speed and fraught with risks.
Community Interviews with Moose FM
“The crisis in the world is so big that each of us will have to take maximum risk now to put this disease to a stop,” said Paul Stoffels, chief scientific officer at Johnson & Johnson , which has partnered with the U.S. government on a $1 billion investment to speed development and production of its still-unproven vaccine.
Story continues below advertisement
“If it fails,” Stoffels told Reuters, “it will be bad.”
1:07Coronavirus outbreak: Europe’s first COVID-19 vaccine trial underway in U.K.
Coronavirus outbreak: Europe’s first COVID-19 vaccine trial underway in U.K. » READ MORE FROM GLOBAL NEWS